Cargando...
Effect of liraglutide vs. placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: a randomized controlled trial
AIMS: To examine how circulating GLP-1 concentrations during liraglutide treatment relate to its therapeutic actions on glucose and weight, and to study the effects of liraglutide on other proglucagon-derived peptides (PGDPs), including endogenous GLP-1, GLP-2, glucagon, oxyntomodulin, glicentin, an...
Gardado en:
| Publicado en: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7856054/ https://ncbi.nlm.nih.gov/pubmed/33140542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14242 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|